tiprankstipranks
Genmab A/S (GMAB)
NASDAQ:GMAB
US Market

Genmab (GMAB) Technical Analysis

Compare
605 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
2Neutral
7Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Genmab A/S’s (GMAB) Moving Averages Convergence Divergence (MACD) indicator is 0.21, suggesting Genmab A/S is a Sell.
Genmab A/S’s (GMAB) 20-Day exponential moving average is 20.61, while Genmab A/S’s (GMAB) share price is $22.44, making it a Buy.
Genmab A/S’s (GMAB) 50-Day exponential moving average is 20.88, while Genmab A/S’s (GMAB) share price is $22.44, making it a Buy.

Genmab (GMAB) Pivot Points

Feb 21, 2025, 05:14 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
20.98
21.22
21.59
21.83
22.20
22.44
22.81
Fibonacci
21.22
21.45
21.59
21.83
22.06
22.20
22.44
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Genmab (GMAB) Moving Averages

Feb 21, 2025, 05:14 PM
Period
Simple
Exponential
MA5
21.68Buy
21.60Buy
MA10
20.40Buy
20.95Buy
MA20
20.20Buy
20.61Buy
MA50
20.73Buy
20.88Buy
MA100
21.62Buy
21.95Buy
MA200
24.45Sell
24.29Sell
Genmab A/S’s (GMAB) 10-Day exponential moving average is 20.95, while Genmab A/S’s (GMAB) share price is $22.44, making it a Buy.
Genmab A/S’s (GMAB) 100-Day exponential moving average is 21.95, while Genmab A/S’s (GMAB) share price is $22.44, making it a Buy.
Genmab A/S’s (GMAB) stock price is $22.44 and Genmab A/S’s (GMAB) 50-day simple moving average is 20.73, creating a Buy signal.
Genmab A/S’s (GMAB) stock price is $22.44 and Genmab A/S’s (GMAB) 100-day simple moving average is 21.62, creating a Buy signal.
Genmab A/S’s (GMAB) stock price is $22.44 and Genmab A/S’s (GMAB) 200-day simple moving average is 24.45, creating a Sell signal.

Genmab (GMAB) Technical Indicators

Feb 21, 2025, 05:14 PM
Name
Value
Implied Action
RSI (14)
66.57
Neutral
STOCH (9,6)
97.98
Sell
STOCHRSI (14)
97.98
Sell
MACD (12,26)
0.21
Sell
ADX (14)
22.00
Neutral
Williams %R
-2.81
Sell
CCI (14)
150.27
Sell
ATR (14)
0.60
-
Ultimate Oscillator
77.25
Buy
ROC
13.28
Buy
Genmab A/S’s (GMAB) Relative Strength Index (RSI) is 66.57, creating a Neutral signal.
Genmab A/S’s (GMAB) Trend Strength Indicator (ADX) is 22.00, creating a Neutral signal.
Genmab A/S’s (GMAB) Commodity Channel Index (CCI) is 150.27, creating a Sell signal.
Genmab A/S’s (GMAB) Price Rate of Change (ROC) is 13.28, creating a Buy signal.

FAQ

Is GMAB a Buy, Hold, or Sell?
Based on GMAB’s technical indicators, GMAB is a Buy.
    What is GMAB’s RSI (14)?
    GMAB’s RSI (14) is 66.57, which suggests GMAB is a Neutral.
      What is GMAB’s MACD?
      GMAB’s MACD is 0.21, which suggests GMAB is a Sell.
        What is GMAB’s 5-day moving average?
        GMAB’s 5-day moving average is 21.68, which suggests GMAB is a Buy.
          What is GMAB’s 20-day moving average?
          GMAB 20-day moving average is 20.20, which suggests GMAB is a Buy.
            What is GMAB’s 50-day moving average?
            GMAB’s 50-day moving average is 20.73, which suggests GMAB is a Buy.
              What is GMAB’s 200-day moving average?
              GMAB’s 200-day moving average is 24.45, which suggests GMAB is a Sell.
                What is GMAB’s Williams % R (14)?
                GMAB’s Williams % R (14) is -2.81, which suggests GMAB is a Sell.
                  What is GMAB’s CCI (14)?
                  GMAB’s CCI (14) is 150.27, which suggests GMAB is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis